Lundbeck, Debiopharm Join List of Pharmas Looking to RNAi
February 03, 2011
Lundbeck, Debiopharm Join List of Pharmas Looking to RNAi
While a handful of pricey deals have dominated the headlines, a handful of other companies over the past year have formed more modest collaborations to see whether they can take advantage of RNAi as a therapeutic modality.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.